Medical technology company Nanox has priced its initial public offering (IPO) of 9.2 million shares to the tune of $18 per share.
The gross proceeds of the offering are expected to be $165.2 million. Nanox also granted underwriters a 30-day option to purchase up to an additional 1.4 million ordinary shares at the IPO price, less underwriting discounts and commissions.
Nanox expects the shares to begin trading on NASDAQ on August 21 and the offering is expected to close on August 25, subject to customary closing conditions.
Nanox has developed Nanox.Arc, an x-ray device with a futuristic design that's based on the design of the biobed from "Star Trek." Nanox.Cloud is companion software designed for image archiving and image review, with built-in smart features for billing and reporting.
